Population-based Incidence and Survival for Primary Central Nervous System Lymphoma in Korea, 1999-2009
Sang-Hoon Shin, Kyu-Won Jung, Johyun Ha, Seung Hoon Lee, Young-Joo Won, Heon Yoo
Cancer Res Treat. 2015;47(4):569-574.   Published online 2015 Feb 12     DOI: https://doi.org/10.4143/crt.2014.085
Citations to this article as recorded by Crossref logo
Changing Incidence and Survival of Primary Central Nervous System Lymphoma in Australia: A 33-Year National Population-Based Study
Alexandra L. Farrall, Justine R. Smith
Cancers.2021; 13(3): 403.     CrossRef
Eye involvement in primary central nervous system lymphoma
Alexandra L. Farrall, Justine R. Smith
Survey of Ophthalmology.2020; 65(5): 548.     CrossRef
Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter study
Chava Perry, Sharon Ben Barouch, Neta Goldschmidt, Nadav Sarid, Yair Herishanu, Lev Shvidel, Osnat Bairey, Noa Lavi, Netanel Horowitz, Avraham Avigdor, Eyal Lebel, Orit Sofer, Ron Ram, Irit Avivi
American Journal of Hematology.2019; 94(9): 992.     CrossRef
Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the Netherlands, 1989–2015
M van der Meulen, A G Dinmohamed, O Visser, J K Doorduijn, J E C Bromberg
Leukemia.2017; 31(8): 1822.     CrossRef
Role of radiation therapy in primary central nervous system lymphoma
Hyeon Kang Koh, Il Han Kim, Tae Min Kim, Do Hoon Lim, Dongryul Oh, Jae Ho Cho, Woo-Chul Kim, Jin Hee Kim, Woong-Ki Chung, Bae-Kwon Jeong, Ki Mun Kang, Semie Hong, Chang-Ok Suh, In Ah Kim
Journal of Neuro-Oncology.2017; 135(3): 629.     CrossRef